3 Marijuana Stocks Targeting New Highs

Last month, the United States Drug Enforcement Administration (DEA) placed Epidiolex, a proprietary oral solution of pure plant-derived cannabidiol (CBD), as a Schedule V drug of the Controlled Substances Act (CSA). This new placement is the least restrictive schedule of the CSA and much less restrictive than CBD’s Schedule 1 classification.

marijuanastocks.jpg

Epidiolex’s recent approval from the Food and Drug Administration (FDA) permits GW Pharma (GWPH) to now market its CBD drug to the masses.  This is the first FDA-approved drug that contains a purified drug substance derived from marijuana, another historic milestone recently reached for the marijuana industry.

This move by the DEA takes a general glance at how the FDA is operating, placing “certain drug products that have been approved by the (FDA) and which contain (CBD) in schedule V of the Controlled Substances Act (CSA),” according to the DEA order.  Although, Epidiolex is currently the only drug that meets the aforementioned criteria, numerous other companies in the space may be hopeful to the idea that these restrictions will diminish in the future.  This news has recently generated increased investor attention to several marijuana stocks.

Integrated Cannabis Company (ICNAF) (ICAN) develops, manufactures, and distributes botanically-based consumable products in Canada and internationally, offering hemp-based CBD nutraceutical infused products under the X-SPRAYS brand and a THC-infused spray product. The company has a distribution agreement with Empower Clinics, throughout 15 of its locations in the U.S and completed a letter of agreement for collaboration on X-SPRAYS products with Canadian-licensed producer GTEC Holdings Ltd. (GTEC) (GGTTF) for the Canadian medicinal and recreational markets.

Most recently, the company announced the successful completion and positive results of a controlled trial of its proprietary sleep product, resulting in improvement in patients’ sleep patterns combined with the unexpected, but highly desirable, decrease in the level of pain. The positive results published in the peer reviewed journal, International Journal of Pharmacy and Life.

New Age Beverage (NBEV) is an organic and natural healthy functional beverage company intending to become the world’s leading healthy beverage company. Earlier this week, the company unveiled its portfolio of CBD-infused beverages at the North American Convenience Store held at the Las Vegas Convention Center on October 8, 2018.

The company has been in talks regarding pre-orders and is lining up retailers seeking to be first to retail the products in states where they are legal, according to Bloomberg. The intended national launch with major retailers and distributors will be as soon as the Farm Bill is enacted, utilizing the company’s existing national distribution footprint.

Michael Cunningham, SVP of sales commented, “The demand and interest for these products is unlike I have ever seen in my career. Customers loved the taste of New Age’s CBD-infused products and many of them committed to bring in the products for sale.

India Globalization Capital, Inc. (IGC) has two lines of business, a legacy infrastructure business and a medical cannabis business that has developed its flagship product for Alzheimer’s patients. The company announced yesterday the filing of a provisional method and composition patent application (IGC-509) on October 4, 2018 with the U.S. Patent and Trademark Office for the treatment of fatigue and energy restoration. This patent filing is part of a series of steps in the development and commercialization plan to create a branded, hemp/CBD sugar-free energy drink.

This news followed the previously announced distribution and partnership agreement for several products including a sugar free, energy drink called ‘Nitro G’ and intention to create a branded, hemp/CBD-infused version of the formulation that addresses market demand for energy drinks with the inclusion of healthy properties derived from hemp including CBD.

“According to a Grand View Research forecast, the global energy drinks market is projected to be almost $85 billion by the year 2025, with non-alcoholic beverage sales expected to account for a significant portion of the market. This represents a unique opportunity for the development and commercialization of a CBD-infused, sugar free energy beverage,” said Ram Mukunda, CEO.

marijuanastockstobuy.jpg

 


Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and Integrated Cannabis Company, Midam is being paid $25,000 per month for a period of 6 months beginning September 4, 2018 and ending March 9, 2019. We own ZERO shares of Integrated Cannabis Company. We may buy or sell additional shares of (ICNAF)/(ICAN) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Integrated Cannabis Company. As of September 28, 2018, a member of MarijuanaStocks.com owns 47,000 shares of Truelieve Cannabis Corp (TCNNF)(TRUL.C) which were purchased in the open market and may be sold at any time.

 

Advertisements

Top Marijuana Stocks To Add To Your Watch-List

For those interested in marijuana stocks, the choices have been relatively slim if major US listings are the main focus. Late last year, Canopy Growth (NYSE:CGC)(WEED) received a minority investment by one of the world’s largest producers & distributors of beer, wine, and spirits, Constellation Brands (NYSE:STZ).

marijuanastocks.jpg

This has placed a bright spotlight on Canadian licensed producers as the markets attempted to digest this information. Unknowingly, they would see that less than a year later, the same beer, wine, and spirits company would then put in another $4 billion to further its investment into the growing cannabis industry.

During the last year, much has changed including the public perception of marijuana. Two-thirds of the country is now in support of recreational legalization and polls continue to show backing for medical use at levels far above 80%. In 1996 California became the first state to allow medical use but only one in four Americans sought to legalize the drug. Since that time, there has been a significant adjustment, and now, according to data from FiveThirtyEight, support for legalization is among the least disruptive issues in the country.

What investors have focused on, outside of the growing support for the drug, has been one country: Canada. As the northern-most nation in North America readies for full legalization, many cannabis stocks with headquarters in Canada have taken charge of the market.

Click Here For Marijuana Stocks Climbing Ahead of Canadian Legalization

Marijuana Stocks Gaining Investors’ Attention

The clock is winding down until Canada’s Bill C-45 will legalize recreational marijuana use to adults across the nation. As this is a big change for our neighbor to the north, politically and socially, Health Canada has conveyed the need for increased education on the matter. As this department of the Canadian government is responsible for national public health, it has launched several public education campaigns as well as investing funds into the effort.

Since last year, there has been a social media campaign in motion and Public Safety began a campaign on drug-impaired driving last fall. As more attention surrounds the legalization of recreational marijuana in Canada, investors are taking increased notice to marijuana stocks lately.

Click Here For 3 Marijuana Stocks That May Go “Higher” This Month

3 Marijuana Stocks Preparing For Legalization In Canada

As Canadian legalization is approaching fast, investors continue to seek new opportunities offered by these hot marijuana stocks. Global legal marijuana spending is forecast to reach $32 billion by 2022, according to a joint Arcview Group and BDS Analytics report. Additionally, analysts from the Cowen Group predict that legal marijuana will generate $75 billion over the next decade or so. As the sector presents favorable prospects, it’s no wonder why numerous marijuana stocks are moving higher.

marijuanastockstobuy.png

The Canadian Marijuana Index, which tracks the leading cannabis stocks operating in Canada, is up nearly 195% over the past year.  The index’s top 3 holdings by market cap include:

As the sector continues to heat up, there are several marijuana stocks following industry momentum.

Integrated Cannabis Company (ICNAF) (ICAN) focuses on the development, manufacturing, marketing, and distribution of botanically-based consumable products in Canada and internationally. Yesterday, Integrated Cannabis announced the successful completion and positive results of a controlled trial of its proprietary Sleep product. The trial was completed with a Southern California pain clinic with positive results published in the peer reviewed journal: International Journal of Pharmacy and Life. The trial resulted in improvement in patients’ sleep patterns combined with the unexpected, but highly desirable, decrease in the level of pain.

The company recently announced the completion of a Letter Agreement to collaborate on X-SPRAYS products for the Canadian market with a Canadian License Producer under Health Canada’s Access to Cannabis for Medical Purposes Regulations, GTEC Holdings Ltd. This news was released after the company signed a distribution agreement with Empower Clinics across its 15 locations in the states of Oregon, Washington and Illinois.

GTEC Holdings (GGTTF) (GTEC) focuses on cultivating, testing, processing, marketing and selling premium quality craft cannabis, with full control from seed to shelf. GTEC currently holds a 100% interest in GreenTec Bio-Pharmaceuticals Corp., Alberta Craft Cannabis Inc. Grey Bruce Farms Inc., Falcon Ridge Naturals Ltd., Tumbleweed Farms Corp., Zenalytic Laboratories Ltd., and Spectre Labs Inc.  The company recently was incorporated into the Horizons Medical Marijuana Life Sciences ETF (HMMJ).

GTEC recently annouced that it has created and trademarked a diverse portfolio of 6 craft cannabis brands. “It was exciting to take on the creative challenge of branding GTEC’s premium cannabis products,” said David Lynn, COO. “We certainly feel that our diversified brand and product portfolio will align well with the multifaceted nature of the craft cannabis market”.

Cronos Group (CRON) is a globally diversified and vertically integrated cannabis company with a presence across five continents and operates two wholly-owned Canadian licensed producers Peace Naturals Project Inc. and Original BC Ltd. Cronos Group and Aleafia Health Inc. (ALEAF) (ALEF) recently announced that the two companies entered into a joint medical cannabis study to improve the management and treatment of insomnia as well as daytime sleepiness.

“Aleafia is excited to participate in a study with Cronos Group, a company with a firm commitment to patient health. For far too long, the answer to a patient’s sleeping disorder or chronic pain has been a prescription and a bottle of pills,” said Dr. Michael Verbora, Aleafia’s Chief Medical Officer. “There is mounting evidence of the risks of prescription sleeping aids including worsening mental health and increased risk of dementia. This study may in part point to medical cannabis as an alternative to harmful prescription drugs.”

marijuanastocks.jpg

 


Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and Integrated Cannabis Company, Midam is being paid $25,000 per month for a period of 6 months beginning September 4, 2018 and ending March 9, 2019. We own ZERO shares of Integrated Cannabis Company. We may buy or sell additional shares of (ICNAF)/(ICAN) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Integrated Cannabis Company. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and GTEC Holdings Inc., Midam is being paid $63,333 per month from the company for a total of 12 months and has received ZERO shares of GTEC Holdings Inc. for a duration of beginning July 10, 2018 and ending July 10, 2019. We may buy or sell additional shares of (GTEC) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

 

Top Canadian Marijuana Stocks To Watch

The focus remains on Canada, as the nation is about to flip the switch and legalize adult-use recreational marijuana in less than two weeks. Canada is the second country, behind Uruguay, to legalize recreational marijuana on a national level and takes the title as the first G7 nation to do so. This highly anticipated upcoming change has triggered an investment boom, increasing the valuations of many Canadian cultivators.

The recreational legal marijuana industry in Canada will be viewed as an experiment of sorts by other governments around the world possibly looking to flip the switch as well. As the industry embarks on this next phase of legal marijuana, there several marijuana stocks benefiting from the speculation of the industry.

Click Here For Marijuana Stocks To Watch Prior To Canadian Legalization

Top Marijuana Stocks To Watch This Month

Marijuana stocks have been capturing significant investor attention as of late.   Due to this spiked increase in attention to the industry, several marijuana ETFs which track the industry have been growing like weeds.  For instance, the ETFMG Alternative Harvest ETF (MJ) has gained over 30% in the past 6 months.

marijuanastocks.jpg

The $4 billion-dollar investment by S&P 500 alcoholic-beverage maker Constellation Brands into the Canadian marijuana company Canopy Growth was a huge industry catalyst, which was trailed by several other companies such as Molson Coors and Coca Cola are seeking ways to merge into this lucrative industry. Since the Constellation deal, investments into the Alternative Harvest ETF have doubled, according to reports.

The Top 5 Holdings of the ETFMG Alternative Harvest ETF are:

  • Aurora Cannabis Corp. (ACB) (ACBFF)
  • Tilray Inc. (TLRY)
  • Cronos Group Inc. (CRON)
  • Canopy Growth Corporation (WEED) (CGC)
  • GW Pharmaceuticals Plc (GWPH)

“The global legal marijuana market size was valued at USD $9.3 billion in 2016 and is expected to exhibit a CAGR of 34.6% during the forecast period. The market is expected to witness significant growth owing to legalization in several countries and high demand for both medical and recreational purposes” according to Grand View Research.

As the industry continues to bud, there are several marijuana stocks that have followed the latest industry moves.

Integrated Cannabis Company (ICNAF) (ICAN)

Canadian-based Integrated Cannabis develops, manufactures, and distributes botanically-based consumable products domestically and internationally, offering eight novel nutraceutical sprays with four infused with hemp-based CBD under the X-SPRAYS brand. The company possesses a market ready Tetrahydrocannabinol (THC)-infused spray product with the required licensing for manufacturing and intends to launch sales towards the end of the year.

Integrated recently announced the completion of a Letter Agreement for a collaboration of X-SPRAYSTM products for the Canadian market with GTEC Holdings Ltd (GTEC)(GGTTF), a Canadian ACMPR-Licensed Producer to co-develop and market products containing CBD and THC for the medical and recreational markets.

This news followed the distribution agreement made with Empower Clinics Inc, an owner and operator of medical marijuana clinics throughout the U.S., with over 25,000 patients across its 15 locations.

Pyxus International (PYX)

Pyxus is a global agricultural company which provides responsibly-sourced, independently-verified, sustainable and traceable products and ingredients. Pyxus, its subsidiaries and affiliates, offer high-quality, distinct brands and products in the leaf tobacco, E-Liquids, industrial hemp and legal cannabis industries.

The company announced yesterday that its indirect Canadian subsidiary, Goldleaf Pharm Inc., received its ACMPR cultivation license from Health Canada on September 28, 2018, and permits Goldleaf Pharm to begin cultivating medicinal cannabis at its Ontario facility.

Pyxus also owns a minority equity position in Criticality, a U.S.-based hemp processor, through an indirect subsidiary. Criticality recently initiated renovation on a 55,000 sq. ft. facility in North Carolina, for an all-natural fluid extraction and purification operation, which when completed will be one of the largest in the state.

Tilray Inc. (TLRY)

Tilray engages in the research, cultivation, processing, and distribution of medical marijuana. Tilray’s main operations are in Canada with international ventures throughout several other countries. The company has distribution deals in seven provinces including British Columbia, Quebec, Manitoba, the Northwest Territories, Ontario. Yukon and Nova Scotia.

High Park Farms™ Ltd., a subsidiary of Tilray, recently announced receiving its sales license from Health Canada under the ACMPR, which now allows High Park Farms to supply and sell marijuana products.

This news followed Canada-based Supreme Cannabis Co. Inc’s 7Acres subsidiary entering a one-year supply agreement with starting Oct. 1, estimated to be valued at $9.3 million.  The agreement entails that 7Acres will provide dried cannabis to Tilray to support medical cannabis patients in Canada.

marijuanastockstowatch.jpg


Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and Integrated Cannabis Company, Midam is being paid $25,000 per month for a period of 6 months beginning September 4, 2018 and ending March 9, 2019. We own ZERO shares of Integrated Cannabis Company. We may buy or sell additional shares of (ICNAF)/(ICAN) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Integrated Cannabis Company.

 

2 Marijuana Stocks To Get On Your Watch-List This Week

Most of the recent hype surrounding the marijuana stock rally is due to Canada’s upcoming legalization of adult recreational marijuana on October 17th . Among the many marijuana stocks are medical marijuana providers Canopy Growth and Aurora Cannabis, and Tilray.

marijuana stocks.png

“You’re seeing a lot of money come in on the hype,” said Richard Acosta, CEO of Inception REIT, a California-based firm that offers real estate-related funding for greenhouses, warehouses and medical labs used in the cultivation processes of marijuana companies.

A report by Arcview Market Research has indicated that North American consumer spending on legal marijuana products is outperforming previous analyst estimates. The report states that sales will increase 33% from 2016, to around $10 billion this year and that the market could hit $24.5 billion by 2021.

The North American Marijuana Index has gained % over the last year and its top holdings by market cap include:

Keeping this new market trend in mind, there are numerous marijuana stocks that have followed the latest moves of the industry.

Click Here For Two Marijuana Stocks That Are Up Over 300%